Jump to content

GPO develops Favipiravir to treat Covid-19


webfact

Recommended Posts

GPO develops Favipiravir to treat Covid-19

By The Nation

 

800_cbc1ea7baec6e9e.jpg?v=1589252985

 

The Government Pharmaceutical Organisation (GPO) developed its version of Favipiravir – one of the drugs used to effectively treat Covid-19 – in mid-March but is expected to take approximately a year before submitting this medicine for registration, said Nuntakan Suwanpidokkul, the director of the GPO’s Research and Development Institute.

 

The GPO has a management plan to build a sufficient stock of Favipiravir pills to support the sustainable treatment of patients in the country.

According to some forecasts, the Covid-19 pandemic will continue for a period of 1-2 years.

 

FujiFilm Toyama Chemical in Japan submitted an application for production of Favipiravir tablets in Thailand in 2010, but it remains only a patent application.

 

If Favipiravir is granted a patent, it will have a protection period of 20 years. However, a domestic formula can be developed without being hit by any lawsuit. Still, if it is produced for the market, it could be sued for patent infringement. Therefore, a voluntary licensing agreement must be negotiated with the patent owner so the GPO can produce and distribute its drug.

 

Pharmaviravir drugs have been urgently imported from FujiFilm Toyama Chemical and China's Zhejiang Hisun Pharmaceutical Company, which received a production licence from Japan.

 

Thailand has imported 187,000 of the tablets and is purchasing another 303,860 in May. The medicines are being distributed to hospitals nationwide.

 

Source: https://www.nationthailand.com/news/30387700

 

nation.jpg

-- © Copyright The Nation Thailand 2020-05-12
 
  • Haha 1
Link to comment
Share on other sites

19 minutes ago, webfact said:

one of the drugs used to effectively treat Covid-19

Encouraging results in some but has not been clinically tested to any sort of standard and a vaccine must be the number 1 goal .. To prevent must be better than trying to cure .. 

Link to comment
Share on other sites

1 hour ago, natway09 said:

What about the "Generic" version out of India ?

They are working on that now : 

Indian Generic Maker Glenmark Seeks to Make Japanese Covid-19  Drug 

Glenmark is attempting to make another antiviral drug favipiravir, originally from Japan. Chinese tests on U.S. and Japanese drugs, throw in an Indian generic maker, intravenous disinfectants ... there's quite the mix chasing the elusive Covid-19 "cure".

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.








×
×
  • Create New...
""